Press Releases
Panama City, Panama, May 22, 2024 (GLOBE NEWSWIRE) -- Gate.io, a leading crypto exchange and Web3 innovator, has announced its 11th-anniversary celebrations, showcasing its milestones and launching prize-winning activities for its global user base. Since its founding in 2013, Gate.io has actively worked to create a secure and cutting-edge platform for cryptocurrency users worldwide. Under the leadership of Founder and CEO Dr. Lin Han, the platform has... (continue reading...)
HONG KONG, May 22, 2024 - (ACN Newswire) - - Kingsoft Corporation Limited ("Kingsoft" or the "Company"; HKEx stock code: 03888), a leading Chinese software and Internet service company, has Announces First Quarter Results for the Period Ended March 31, 2024.
In the first quarter of 2024, the revenue of Kingsoft increased 8% year-on-year to RMB2,136.9 million. Among them, revenue from the office software and services, and online games and others represented 57% and 43%... (continue reading...)
DALLAS--(BUSINESS WIRE)-- AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced it has been selected by the Regional Municipality of Peel (Peel Region) to provide design and engineering services for the expansion of the Clarkson Water Resource Recovery Facility (WRRF) in Ontario’s Peel Region. AECOM will be responsible for the design and implementation of the expansion, providing increased capacity and flexibility to accommodate... (continue reading...)
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases
GENEVA, May 22, 2024 (GLOBE NEWSWIRE) -- Antion Biosciences (Antion), a Geneva-based cell and gene therapy company developing “off-the-shelf” cell therapies, announces the development of next generation anti-CD19 chimeric antigen receptor (CAR) T-cells for B-cell driven autoimmune diseases.
Autoimmunity affects up to 10% of the global population, and the overall burden of care... (continue reading...)
GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that dosing has been initiated in a Phase I study of the drug candidate IRL757. IRL757 has been shown in preclinical disease models to counteract apathy - a condition that impairs the quality of life... (continue reading...)
More Press Releases
View Older Stories-
iClick Interactive Asia Group Limited Receives NASDAQ Deficiency Notice For Failure to Timely File Form 20-F
-
TransUnion to Present at Upcoming Investor Conferences in New York and Chicago
-
FREYR Battery Provides Operations Update
-
Ferguson Share Repurchase Program - Weekly Report
-
Carter’s, Inc. Releases 2023 Raise the Future Impact Report
-
TELUS International Partners with eGain to Elevate its Contact Center as a Service (CCaaS) Offering with Modern Knowledge Management and AI Functionalities
-
Lands' End Announces First Quarter 2024 Earnings Conference Call
-
Ferguson Continues Strategic Growth With Four New Acquisitions
-
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
-
Pediatrix Medical Group To Present at Upcoming Investor Conferences
-
Lands' End Announces First Quarter 2024 Earnings Conference Call
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
WEC Energy Group announces offering of Convertible Senior Notes due 2027 and Convertible Senior Notes due 2029
-
Celebrate Bitcoin Pizza Day with YouHodler: Free Pizza, Crypto Fun, and Cultural Heritage in Italy
-
Forensic Payroll Consultants, Inc. (FPC) Announces Launch of SaaS White-Label Platform for State & Local Payroll Tax ID Registration
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 22
-
Predictiv AI Closes Private Placement Financing And Shares for Debt Transaction
-
Early Leak Unveils Exciting Lineup of Speakers and Sponsors for ADFO Summit 2024
-
Legendary Tenor Andrea Bocelli to take Center Stage at Cunard Queen Anne Naming Ceremony in Liverpool
-
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
-
CCTV+: International Day for Biological Diversity: Yunnan Jinping's "China • Honghe Butterfly Valley" witnesses the peak period of butterfly emergence
-
Hannan Outlines A Significant Copper-Gold Porphyry At Previsto Central, Peru
-
Altamira Gold Drills 146m @ 1g/t Gold at the Intrusive-Hosted Maria Bonita Discovery, Cajueiro Project, Brazil
-
PDD Holdings Announces First Quarter 2024 Unaudited Financial Results
-
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
-
Callinex Announces 2024 Exploration Targets at the Pine Bay Project Located in the Flin Flon Mining District, MB
-
NexGen Releases 2023 Sustainability Report
-
Rohde & Schwarz and VIAVI Solutions Unveil Open RAN and Non-Terrestrial Network Test Solutions
-
Legal-Bay Presettlement Funding Announces 24-48 Hour Turnaround on Personal Injury Loans
-
Target Corporation Reports First Quarter Earnings
-
Amba Announces New President for North America
-
Riata Capital Group Closes RCG Equity Fund II at $285 Million, Exceeding Target
-
CORE Industrial Partners Completes Take-Private of Fathom Digital Manufacturing Corporation
-
ISS, an Independent Proxy Advisory Firm, Recommends Voting “FOR” Each of the Five Proposals at Westwater’s 2024 Annual Shareholder Meeting Scheduled for May 30th
-
Wallbridge Drilling at Fenelon Intersects Near Surface High-Grade Gold Mineralization
-
Monarch Landscape Companies Acquires DynaServ Florida
-
Vice Admiral Collin Green Joins Academy Securities’ Advisory Board and Geopolitical Intelligence Group
-
lululemon athletica inc. Announces First Quarter Fiscal 2024 Earnings Conference Call
-
Photronics Reports Second Quarter Fiscal 2024 Results
-
Parsons Selected For LAWA’s Capital Improvement Program MATOC
-
Form 8.3 - Mattioli Woods
-
Formula Systems Reports First Quarter 2024 Financial Results
-
Form 8.3 - Lok’n Store Group PLC
-
Form 8.3 - Keywords Studios Plc
-
Free Spins and Free Bets a Steal at Juicy Stakes Casino
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Granite Announces Renewal of Normal Course Issuer Bid
-
HSBC - DEALINGS DISCLOSURE - XP Power Limited
-
Form 8.3 - Alpha Financial Markets Consulting Plc
-
Scatec ASA: Mandatory notification of trade by primary insider